Choriogonadotropin alfa biosimilar - Shanghai Bao Pharmaceuticals
Alternative Names: SJ-04Latest Information Update: 21 Feb 2025
At a glance
- Originator Shanghai Bao Pharmaceuticals
- Class Infertility therapies; Peptide hormones; Pituitary gonadotropins; Placental hormone vaccines; Placental hormones; Recombinant proteins
- Mechanism of Action Chorionic gonadotropin stimulants; Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Infertility
Most Recent Events
- 21 Feb 2025 376818 - CTP push- Trial intiated in Intro, KDM DevT and HE
- 16 Oct 2024 Phase-I clinical trials in Infertility in China (SC) (NCT06599528)
- 01 Oct 2024 Suzhou Centergene Pharmaceuticals plans a phase I comparative immunogenicity and pharmacokinetics trial in Healthy subjects in China (SC, Injection) (NCT06599528)